<div class='cut-page'><button class='gotoPage'>Page 1</button> <div class='cut-image'> <amp-img class='cut-thumb gotoPage' alt='Page 1: JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL' src='https://reader036.cupdf.com/reader036/viewer/2022071220/6059c5f8b35d17566e29e4fa/html5/thumbnails/1.jpg' width="142" height="106" layout="responsive"> </amp-img> </div></div><div class='cut-page'><button class='gotoPage'>Page 2</button> <div class='cut-image'> <amp-img class='cut-thumb gotoPage' alt='Page 2: JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL' src='https://reader036.cupdf.com/reader036/viewer/2022071220/6059c5f8b35d17566e29e4fa/html5/thumbnails/2.jpg' width="142" height="106" layout="responsive"> </amp-img> </div></div><div class='cut-page'><button class='gotoPage'>Page 3</button> <div class='cut-image'> <amp-img class='cut-thumb gotoPage' alt='Page 3: JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL' src='https://reader036.cupdf.com/reader036/viewer/2022071220/6059c5f8b35d17566e29e4fa/html5/thumbnails/3.jpg' width="142" height="106" layout="responsive"> </amp-img> </div></div><div class='cut-page'><button class='gotoPage'>Page 4</button> <div class='cut-image'> <amp-img class='cut-thumb gotoPage' alt='Page 4: JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL' src='https://reader036.cupdf.com/reader036/viewer/2022071220/6059c5f8b35d17566e29e4fa/html5/thumbnails/4.jpg' width="142" height="106" layout="responsive"> </amp-img> </div></div><div class='cut-page'><button class='gotoPage'>Page 5</button> <div class='cut-image'> <amp-img class='cut-thumb gotoPage' alt='Page 5: JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL' src='https://reader036.cupdf.com/reader036/viewer/2022071220/6059c5f8b35d17566e29e4fa/html5/thumbnails/5.jpg' width="142" height="106" layout="responsive"> </amp-img> </div></div><div class='cut-page'><button class='gotoPage'>Page 6</button> <div class='cut-image'> <amp-img class='cut-thumb gotoPage' alt='Page 6: JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL' src='https://reader036.cupdf.com/reader036/viewer/2022071220/6059c5f8b35d17566e29e4fa/html5/thumbnails/6.jpg' width="142" height="106" layout="responsive"> </amp-img> </div></div><div class='cut-page'><button class='gotoPage'>Page 7</button> <div class='cut-image'> <amp-img class='cut-thumb gotoPage' alt='Page 7: JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL' src='https://reader036.cupdf.com/reader036/viewer/2022071220/6059c5f8b35d17566e29e4fa/html5/thumbnails/7.jpg' width="142" height="106" layout="responsive"> </amp-img> </div></div><div class='cut-page'><button class='gotoPage'>Page 8</button> <div class='cut-image'> <amp-img class='cut-thumb gotoPage' alt='Page 8: JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL' src='https://reader036.cupdf.com/reader036/viewer/2022071220/6059c5f8b35d17566e29e4fa/html5/thumbnails/8.jpg' width="142" height="106" layout="responsive"> </amp-img> </div></div><div class='cut-page'><button class='gotoPage'>Page 9</button> <div class='cut-image'> <amp-img class='cut-thumb gotoPage' alt='Page 9: JCRファーマ株式会社 l 希少疾病領域のスペシャリティファーマ · 2 2009, 201 1 ) PTH PTH PTH [Intact PTH] ñJbYÞL(Ca) 8.4 2.8 — 65pg/mL 10.0mg/dL 4.5mg/dL' src='https://reader036.cupdf.com/reader036/viewer/2022071220/6059c5f8b35d17566e29e4fa/html5/thumbnails/9.jpg' width="142" height="106" layout="responsive"> </amp-img> </div></div>